Bibliographic Details
| Title: |
TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial. |
| Authors: |
Pfeiffer, Per1,2 (AUTHOR) per.pfeiffer@rsyd.dk, Yilmaz, Mette3 (AUTHOR), Möller, Sören2,4 (AUTHOR), Zitnjak, Daniela5 (AUTHOR), Krogh, Merete1 (AUTHOR), Petersen, Lone Nørgård6 (AUTHOR), Poulsen, Laurids Østergaard3 (AUTHOR), Winther, Stine Braendegaard1 (AUTHOR), Thomsen, Karina Gravgaard1 (AUTHOR), Qvortrup, Camilla6 (AUTHOR) |
| Source: |
Lancet Oncology. Mar2020, Vol. 21 Issue 3, p412-420. 9p. |
| Database: |
Academic Search Ultimate |
